Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

John C Cambier

Showing results (11-20 of 107) with videos related to

Pageof 11
Sort By:
Current Diabetes Reports|September 6, 2014
Role of B lymphocytes in the pathogenesis of type 1 diabetesRochelle M Hinman, John C Cambier
Arthritis Research & Therapy|July 1, 2004
Ageing, autoimmunity and arthritis: senescence of the B cell compartment - implications for humoral immunitySara A Johnson, John C Cambier
Oncogene|October 19, 2004
Src-family kinases in B-cell development and signalingStephen B Gauld, John C Cambier
F1000Prime Reports|October 30, 2013
B lymphocyte antigen receptor signaling: initiation, amplification, and regulationThomas A Packard, John C Cambier
European Journal of Immunology|October 10, 2023
Therapeutic tactics for targeting B lymphocytes in autoimmunity and cancerScott M Wemlinger, John C Cambier
Frontiers in Immunology|April 24, 2018
Putting on the Brakes: Regulatory Kinases and Phosphatases Maintaining B Cell AnergyS Elizabeth Franks, John C Cambier
Current Opinion in Rheumatology|August 10, 2006
B cell receptor signaling in human systemic lupus erythematosusAimee E Pugh-Bernard, John C Cambier
Immunological Reviews|August 24, 2010
Molecular underpinning of B-cell anergyYuval Yarkoni, Andrew Getahun, John C Cambier
Journal of Autoimmunity|July 9, 2015
B cell expression of the SH2-containing inositol 5-phosphatase (SHIP-1) is required to establish anergy to high affinity, proteinacious autoantigensJanie Akerlund, Andrew Getahun, John C Cambier
Journal of Immunology (Baltimore, Md. : 1950)|October 22, 2009
Establishing anergy as a bona fide in vivo mechanism of B cell toleranceAndrew Getahun, Shannon K O'Neill, John C Cambier
Pageof 11

Showing results (11-20 of 107) with videos related to

Sort By:
Pageof 11
Current Diabetes Reports|September 6, 2014
Role of B lymphocytes in the pathogenesis of type 1 diabetesRochelle M Hinman, John C Cambier
Arthritis Research & Therapy|July 1, 2004
Ageing, autoimmunity and arthritis: senescence of the B cell compartment - implications for humoral immunitySara A Johnson, John C Cambier
Oncogene|October 19, 2004
Src-family kinases in B-cell development and signalingStephen B Gauld, John C Cambier
F1000Prime Reports|October 30, 2013
B lymphocyte antigen receptor signaling: initiation, amplification, and regulationThomas A Packard, John C Cambier
European Journal of Immunology|October 10, 2023
Therapeutic tactics for targeting B lymphocytes in autoimmunity and cancerScott M Wemlinger, John C Cambier
Frontiers in Immunology|April 24, 2018
Putting on the Brakes: Regulatory Kinases and Phosphatases Maintaining B Cell AnergyS Elizabeth Franks, John C Cambier
Current Opinion in Rheumatology|August 10, 2006
B cell receptor signaling in human systemic lupus erythematosusAimee E Pugh-Bernard, John C Cambier
Immunological Reviews|August 24, 2010
Molecular underpinning of B-cell anergyYuval Yarkoni, Andrew Getahun, John C Cambier
Journal of Autoimmunity|July 9, 2015
B cell expression of the SH2-containing inositol 5-phosphatase (SHIP-1) is required to establish anergy to high affinity, proteinacious autoantigensJanie Akerlund, Andrew Getahun, John C Cambier
Journal of Immunology (Baltimore, Md. : 1950)|October 22, 2009
Establishing anergy as a bona fide in vivo mechanism of B cell toleranceAndrew Getahun, Shannon K O'Neill, John C Cambier
Pageof 11